APA Alıntı

Chilcott, J., McCabe, C., Tappenden, P., O'Hagan, A., Cooper, N. J., Abrams, K., & Claxton, K. (2003). Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis. BMJ Group.

Chicago Stili Alıntı

Chilcott, Jim, Chris McCabe, Paul Tappenden, Anthony O'Hagan, Nicola J. Cooper, Keith Abrams, ve Karl Claxton. Modelling the Cost Effectiveness of Interferon Beta and Glatiramer Acetate in the Management of Multiple Sclerosis. BMJ Group, 2003.

MLA Alıntı

Chilcott, Jim, et al. Modelling the Cost Effectiveness of Interferon Beta and Glatiramer Acetate in the Management of Multiple Sclerosis. BMJ Group, 2003.